chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received 1st dose of Pfizer COVID vaccine at another location had a change of duty station to overseas in  prior to receiving 2nd dose of Pfizer vaccine. Moderna vaccine is the only mRNA vaccine available at new overseas duty station. The patient was administered a 2nd dose with Moderna vs Pfizer from CDC guidance. Pt was educated about this and questions were answered. No adverse reactions were noticed during observation period and patient released.
Covid arm - red itchy circle on upper arm, has grown 4 x in size from Friday to Sunday. Arm is very hot, and achy.
Patient complained about dizziness, tingling of arms, and throat closing 5 minutes after the shot.  Symptoms resolved after about 10 minutes and patient developed slight rash on chest.
skin on head started to feel itchy; urticaria on her body; some rash on the area on front of both thighs; This is a spontaneous report from a non-contactable consumer (patient).  A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on the left arm, on 11Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. After 3 days since he vaccination, on Jan2021, patient's skin on head started to feel itchy, and it lasted for so many days, and recently her body feels itchy too. After that she checked her body and found urticaria on her body, under arm pit of both armpit, vaccination side was on her left side, on her belly in some areas, and there was also some rash on the area on front of both thighs. There was also in her head, beneath her hair. Patient had never had before the Covid vaccine and was still experiencing those effects. Outcome of the events was unknown. Patient was due to go back 08Feb2020 of the second dose  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Flu vaccine 9-25-12. (L) flank pain & hyperesthesia 9-26-12. Hx & exam c/w zoster.
Never been positive for COVID-19 but status post vaccine injection experiencing ongoing aching, numbness in deltoid region at injection site X 5 months, radiating pain down left arm, muscle spasms and twitching.  Tried to see if symptoms would resolve by themselves but concerned after X 5 months and pain is worsening and is keeping me awake at night. now experiencing  muscle spasms and heart palpitations.
Severe body chills, body temperature checked orally @ 93.9, then 3days of liquid diarrhea.
By 7:30 p.m. I had a splitting headache which remains even with TYLENOL. This morning at 5:00 a.m. awoke with Chills, low grade fever, swollen glands in lower throat, pain in all muscles and joints. Redness at injection site and pain. My arthritic joints in my hands are swollen. Decrease in appetite and extreme fatigue. Tonight my teeth ache and I have a stuffy nose now as well. My ears are sore as well. After 24 plus hours I am the same with these symptoms.
Patient states that her arm started swelling the night of the injections and the next morning it was red and swollen.
Overnight fever, significant left abdominal and chest pain, severe dizziness and lightheadedness. Symptoms consistent with vestibular neuritis being experienced for four weeks thus far to include dizziness, vertigo, nausea, loss of appetite, concentration problems and significant fatigue. Abdominal Ultrasound revealed enlarged spleen by at least 3 cm. Treatment included ER visit to rule out cardiac issue via XRay, EKG and blood tests. Additional Urgent Care and Family Doctor ruled out COVID (negative test) and other infections such as Lyme, Mononucleosis, and others. Awaiting referral for ENT and Hematology.
After nine days, I then had a reaction with a redness, itch and slight soreness in injection area.  I did not have a reaction at the time of injections and still have the redness but the itch has lessened
Left arm swollen, redness, warm to touch and pain at site of injection - Instructed mother probable reaction to vaccine referred to PMD today
Patient states the next day after vaccination felt tired and a little sore throat. Second day after vaccination patient entire body feels itchy,  scratches skin turns red.
shortly after first shot my right arm started to hurt , after the second shot seemed to get worse.  Thought is was just sore and months could no longer raise it up dr said frozen shoulder
Dizziness and lightheadedness; This is a spontaneous report from a non-contactable consumer, the patient. A 49-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 07Mar2021 at 16:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included IgA deficiency and allergy to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Mar2021, the patient experienced dizziness and lightheadedness persisting 2-3 post vaccine. The adverse event resulted in a visit to the doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event dizziness and lightheadedness. The clinical outcome of the event dizziness and lightheadedness was not recovered at the time of the report.   No follow-up attempts are possible. No further information is expected.
off label use; Patient had moderna and received 3rd pfizer vaccine; This is a spontaneous report from a contactable pharmacist. A 77-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: 301358A) via intramuscular route of administration, administered in Arm Left on 03Oct2021 16:30 as dose 3 (booster), single for covid-19 immunisation; influenza vaccine inact sag 3v (FLUAD), via an unspecified route of administration on 03Oct2021 (Lot Number: 312849) at unspecified dose for an unspecified indication. The patient medical history and concomitant medications were not reported. Patient had no known allergies. Patient has previously received 2 doses of Moderna vaccine. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not having covid prior vaccination and has not been covid tested post vaccination. On 03Oct2021 16:30, patient had moderna and received 3rd pfizer vaccine. Patient has not received any treatment for adverse event. The outcome of the events was unknown. Follow-up attempts are completed. No further information is expected.
localized reaction, swelling of arm below vaccination site. warm to touch, appeared to be a rash (localized), slight itching.
Immediate swelling, warm, pruritus at vaccine site (left shoulder) followed by waxing and waning of the same symptoms over the following week.
Received vaxs on 03/30 at which time he also had right otitis media which was treated with Amoxicillin.  On 04/07, eight days post vax, child experienced temperature of 105.9 (R), morbiliform rash systemic, rhinorrhea. Had same symtoms along with mild tonsillar exudate. Tests performed. In addition to Amox, received ceftriaxone injection.  Follow up in office 04/08, and again 04/12 - resolving otitis media and vaccine reaction.
On October 25, 2023 at approximately 12:45pm I was given a flu shot vaccine by the physician?s assistant at clinic. At 3:23pm I received a call from Dr. to call her back. After I called her back, she proceeded to tell me that the wrong vaccine shot was given to me. Instead of the flu shot I had received the tetanus shot that I did not consent to. She asked me to come back to the office to get the flu shot. When I revisited her office they explained to me that the assistant mistaken the two boxes of vaccines and explained they looked identical so the wrong shot was taken out. They did not notice the error until they counted the syringes at the end of the day.
Started with mouth numbness and progressed to full paralysis on left side of face. Diagnosed in ER with Bell's palsy
I've had 2 doses but they were more than 6 months apart; This case was reported by a consumer via (Shingrix GSK) interactive digital media and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had 2 doses but they were more than 6 months apart, which led to drug dose administration interval too long.  The physician suggested that he/she did not need another while his/her family physician said had to start over. The reporter was asking if she/she need to start the series again. Follow up would not possible as no contact details were available.
Per a conversation with the mother he was admitted into ICU for several days with H1N1.
erythematous areas around inject site; spread to chest & neck area; DPH; rash started 20 mins p/inject; lasted aprox 30 mins p/med;
NURSE'S NOTES: Pt given first Hpv shot and got to check out window and pt passed out. Pt did not hit her head or any other areas of the body.Pt was pale in color. Bp 110/70  P- 80 .Pt given sips of water and stated that she felt fine. Taken to exam room for observation for any other symptoms. Bp 108/ 70 P- 84. Pt continuing taking water. Pt with mother and waited in room. Pt left with mother and was not dizzy, light headed or having any other symptoms.
New swelling, itching. redness at injection site. -about 1.5 by 3 inches - oval shape - 9 days after injection date
SUMMARY OF PATIENT'S DESCRIPTIONS FROM PHONE CONVERSATION ON 1/16/22-  INJECTION SITE SWOLLEN, BURNING ACHING PAINS AND OTHER SHARP PAINS OCCURRING ALL OVER BODY.  WHEN I PROMPTED HER WITH QUESTIONS TO FURTHER DESCRIBE, I LEARNED THAT HER PAINS ARE BILATERAL AND INCLUDE BOTH LOWER AND UPPER EXTREMETIES SHE DESCRIBES HER SYMPTOMS AS SIMILAR TO A FIBROMYALGIA FLARE UP SHE DENIES RECEIVING MEDICAL CARE OR TREATMENT RELATED TO THIS VACCINE DOSE I SUGGESTED THAT SHE SEEK MEDICAL ATTENTION, AND TO UPDATE US, HER DOCTOR, AND VAERS IF STATUS CHANGES WITH HEALTH OR TREATMENTS THAT SHE RECEIVES RELATED TO THIS VACCINE DOSE
Do you think it caused my brain to swell?; Bipolar manic episode; She had a manic attack after receiving the first dose of the vaccine; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sponsored program. A 64-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 24Apr2021 13:30 (Lot Number: ER8729) at 64-years-old as 1ST DOSE, SINGLE for covid-19 immunisation  .  Medical history included bipolar 1 from 1972 and ongoing , manic attack, had a spat of anorexia. Concomitant medication included diazepam (VALIUM) taken for anxiety and benzodiazepine.  The patient previously took the measles. The patient asked "do you think it caused my brain to swell", The patient experienced bipolar manic episode, she had a manic attack after receiving the first dose of the vaccine on 25Apr2021. No treatment for the events. The outcome of events was unknown.
RA flare up, had to call off work; This case was reported by a other health professional via call center representative and described the occurrence of rheumatoid arthritis flare up in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain in extremity (1st dose received in Feb 2022, reference case US2022AMR109363). Concurrent medical conditions included rheumatoid arthritis (diagnosed about 4 years prior to the reporting). Concomitant products included etanercept (Enbrel) and methotrexate.   On 20th July 2022, the patient received the 2nd dose of Shingrix. In July 2022, less than a week after receiving Shingrix, the patient experienced rheumatoid arthritis flare up (serious criteria GSK medically significant). On an unknown date, the outcome of the rheumatoid arthritis flare up was not recovered/not resolved.   It was unknown if the reporter considered the rheumatoid arthritis flare up to be related to Shingrix.     Linked case(s) involving the same patient:  US2022AMR109363   Additional Information: GSK Receipt Date: 21-JUL-2022. Reporter's Comments: The reporter was also a patient and she was paramedic, work in a hospital. The reporter stated, she was wondered about the Shingrix caused an rheumatoid arthritis flare up, it seems that was what happened with her. The reporter stated that, it was a pretty bad flare up so she became curious if others have reported this. The reporter still would have chosen to get the vaccine. The patient had to call off work after second dose. The reporter stated, she never missed work for an unscheduled event in years.  The patient was diagnosed with rheumatoid arthritis about 4 years before from the reporting date, but really started more aggressive treatment before about 1.5 years. The patient guessed that she had the worst symptoms on the day of reporting (she hoped that anyway). The reporter mentioned, she like research so she would love to read anything related and asked if anyone reported a flare up from their rheumatoid arthritis after a vaccine. The reporter consented to follow up. Additional supportive information: This case has been linked to the case US2022AMR109366 and US2022AMR109365 reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR109363:Same reporter US-GSK-US2022AMR109365:Same reporter US-GSK-US2022AMR109366:Same reporter
had a stokes; Don't recommend it if recipient is still recovering from shingles; This case was reported by a consumer via interactive digital media and described the occurrence of stroke in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Concurrent medical conditions included shingles.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced stroke (serious criteria GSK medically significant) and drug use for unapproved indication. On an unknown date, the outcome of the stroke and drug use for unapproved indication were unknown.   It was unknown if the reporter considered the stroke to be related to Shingles vaccine.     Additional Information: GSK receipt date: 18-Aug-2022 Reporter's comment: The case was received from the patient's wife via interactive digital media. The patient had a stokes after vaccination.  The reporter stated that did not recommend vaccine if recipient was still recovering from shingles. Additional supportive information: The patient received the vaccine when he still having shingles, which led to drug used for unapproved indication. The follow-up could not be possible as no contact details were available.
Pt admitted to Hospital on 2/23/2022 with weakness, dizziness, recent falls. Pt tested positive for COVID upon admission. Pt states that they are COVID vaccinated plus booster. Manufacturer information and dates of vaccine are unknown at this time.
Missed period/10th day of late period; This is a spontaneous report received from a contactable consumer (patient). This 39-year-old female patient received dose 2 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EW0158) via an unspecified route of administration on 05May2021 at 15:45 (at the age of 39-years-old) and dose 1 of BNT162B2 (lot number EW0151) via an unspecified route of administration on 05May2021 at 16:00 (as reported) as single doses in the left arm for COVID-19 immunization. Medical history included miscarriage in Nov2020 and allergy to cephalosporins. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine. Concomitant medications were not reported. On an unspecified date the patient experienced missed period. Today (30May2021) was the tenth day of late period. The patient had a pretty regular menstrual cycle. She had a miscarriage in Nov2020 but not event that affected her cycle. There was zero percent chance of being pregnant again. She had not had sex in months. The patient did not receive any treatment for the event. The outcome of late period was unknown. It was also reported that since the vaccination the patient had not been tested for COVID-19.
Onset of tingling and numbness about 10 days, post flu shot, then start in his feet/toes and then progressed to the fingers and hands. Progressed up the left arm and shoulder. Legs became weak and seem unable to have the strength to walk up down stairs. No fever, chills. No SOB, dysphagia.
5/2/18 note: Pt c/o severe ached and pain all over his body muscles and joints, HA, subjective fever, fatigue, sweating. Headache, Myalgia, Arthralgia, Fever and fatigue, sweating, chills. Acetaminophen/hydrocodone 5/325 mg tablet tab TID.
mom comes in today 25APR96 & states pt cried for almost 24hr straight p/the 1st vax given 15FEB96;
had sz w/DTP; pt vax 4-5sz genralized 3-5 mins, t105;
Pneumococcal immunization (1st dose) was given 7/19/06 in the a.m. (I don't remember location?) The following day (nearly 24 hours later), the patient had developed a mild looking rash on stomach that itched. The rash then began to appear (1-2 hours later) all over the body (including face). Throughout the day it would minimize in an area and then appear again. The patient showed only signs of itching discomfort. There was no fever and no difficulity breathing. The physician's office was contacted by 4-5 p.m. that day and was seen by the physician listed above. It was determined the patient had an allegeric reaction to the vacinne and would not be getting a second dose. A liquid form medicine (steriod) was prescribed. The patient showed signs of relief following the doses, even though it appeared initially more hives were breaking out. Benadryl was administed at night and Claritin-D in the morning.  The hives disappered over the next fews days and the above medicines were given to the patient for approximately a week. The patient showed no other signs of reaction and was fine.
Case number PHEH2015US022650 is an initial spontaneous report received from a pharmacist on 03 Nov 2015 and quality assurance department (QA reference nr. 1008394) on 05 Nov 2015 (combined report). This report refers to a 86 years old male patient. Medical history and concomitant medications were not reported. It was reported that the patient may have received expired FLUVIRIN (batch number: 146304) intramuscularly on 02 Nov 2015. The reporter wonders if the PFS was mislabeled because it came with a shipment that included other syringes with different lot number and expiration date. No adverse event was reported.
aliterature report was receivced on 11/11/92, concerning a 60 year old female patient who experienced relapse of severe plasti anemic afterreceiving fluvirin in 11, 1998. the patient's illness was proceede by an influenza-like condition . the patient was diagnosed as having severe aplastic anemia in january,1996 when she was presenterd to the hospital with profound pancytopenia (Hb 3.9 g/dl. WBC 2.2X 10-9.L, Neutrophil count.  Follow up on 02/05/2003: "A follow up report was received from a health care professional indicating that the 6 year old female vaccinee experienced a relapse of aplastic amnesia 3 months after receiving Fluvirin on 10/14/1998.  The vaccinee was first diagnosed in 01/1996 with aplastic anaemia and want into remission in October 1998.  The vaccinee had had a previous Fluvirin vaccination on 10/20/1997.  Concomitant medication reported included cyclosporine which she had been taking due to transplant for 3 months prior to the relapse.  On 01/06/1999 the vaccinee experienced a relapse of aplastic anaemia.  The reporter indicated that the vaccinee seemed to have recovered by July 2000.  There was insufficient information to determine the reporter's causality assessment.
COVID 19; COVID 19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Jan2021 at 15:00 as dose 1, single (Lot number: EL1042), in left arm, on 05Feb2021 at 14:00 as dose 2, single (Lot number: EL3302), in left arm, on 17Aug2021 at 13:00 as dose 3 (booster), single (Lot number: FC3180), in left leg and on 28Jan2022 at 13:00 as dose 4 (booster), single (Lot number: 33130BA) at the age of 47 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Multiple Sclerosis" (unspecified if ongoing), notes: (taking immunosuppressant); "Beta Thalassemia Minor" (unspecified if ongoing). Concomitant medication(s) included: GILENYA, start date: 22Nov2020. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". Therapeutic measures were taken as a result of vaccination failure, covid-19.  No follow-up attempts are possible. No further information is expected.
postmenopausal menstrual cyle x 4 days 2-3 weeks after vaccination.  She has had no period the past 4 years.  She has also had palpitations starting shortly after vaccination, chest pain starting on 9/29/21.
I was fatigued within the hour of the shot. I left work because I did not feel well, I was aching and feverish. The next day, lots of pain in injection site and aches and fever.
No additional AE reported.; temperature excursion 47.9; This spontaneous report was received from the vaccine provider and refers to a 12-month-old female patient.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 27-DEC-2022, the patient was vaccinated with an improper stored hepatitis a vaccine, inactivated (VAQTA) dose 1 lot #W017343, expiration date: 13-DEC-2023, administered intramuscularly on the right tight for prophylaxis (strength was not provided) following a temperature excursion  of 47.9 Degrees Fahrenheit for 47 minutes on 01-DEC-2022 (product storage error), it was stated that a data logger was involved. No additional adverse event was reported.  This is one from several cases from the same reporter. ; Sender's Comments:  US-009507513-2301USA009943: US-009507513-2301USA001175: US-009507513-2301USA009024: US-009507513-2301USA009110: US-009507513-2301USA009918: US-009507513-2301USA009943: US-009507513-2302USA000721: US-009507513-2302USA000721:
11/3: shortness of breath, heart palpitations, elevated D-dimer, elevated CK, elevated Cr 11/4: elevated CK, D-Dimer 11/8:  numbness to left arm, abnormal EKG, tachycardia, arrhythmia 11/12:  elevated CK, chest pain  Treated with IV fluids, Lovenox (11/3), IV fluids, Aspirin (11/12)
pt recv vax;devel sudden limp, unresponsive;was described as pale white & not breathing for less than 1 min;brief CPR by babysitter; no cyanosis;